Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of eight modern preoperative scoring systems for survival prediction in patients with extremity metastasis.
Lee TY, Chen YA, Groot OQ, Yen HK, Bindels BJJ, Pierik RJ, Hsieh HC, Karhade AV, Tseng TE, Lai YH, Yang JJ, Lee CC, Hu MH, Verlaan JJ, Schwab JH, Yang RS, Lin WH. Lee TY, et al. Among authors: yang rs, yang jj. Cancer Med. 2023 Jul;12(13):14264-14281. doi: 10.1002/cam4.6097. Epub 2023 Jun 12. Cancer Med. 2023. PMID: 37306656 Free PMC article.
International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
Tseng TE, Lee CC, Yen HK, Groot OQ, Hou CH, Lin SY, Bongers MER, Hu MH, Karhade AV, Ko JC, Lai YH, Yang JJ, Verlaan JJ, Yang RS, Schwab JH, Lin WH. Tseng TE, et al. Among authors: yang rs, yang jj. Clin Orthop Relat Res. 2022 Feb 1;480(2):367-378. doi: 10.1097/CORR.0000000000001969. Clin Orthop Relat Res. 2022. PMID: 34491920 Free PMC article.
DNTT-mediated DNA Damage Response Drives Inotuzumab Ozogamicin Resistance in B-cell Acute Lymphoblastic Leukemia.
Escherich CS, Moriyama T, Li Z, Hsiao Y, Yang W, Li Y, Reyes N, Walker M, Budhraja A, Bhatara S, Diaz-Flores E, Stock W, Paietta E, Konopleva MY, Kornblau SM, Litzow MR, Inaba H, Pui CH, Opferman JT, Loh ML, Yu J, O'Brien M, Evans WE, Yang JJ. Escherich CS, et al. Among authors: yang jj. Blood. 2024 Dec 27:blood.2024026085. doi: 10.1182/blood.2024026085. Online ahead of print. Blood. 2024. PMID: 39791601
Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL.
Zhang W, Cai J, Wang X, Ma Y, Zhu X, Yu J, Xiao P, Gao J, Fang Y, Liang C, Li X, Zhou F, Zhai X, Xu X, Tian X, Liu A, Wang N, Zhu J, Wang L, Cheng FWT, Yang L, Zhang G, Cheng C, Yang JJ, Shen S, Li CK, Li B, Jiang H, Pui CH. Zhang W, et al. Among authors: yang jj. Blood. 2024 Dec 30:blood.2024026381. doi: 10.1182/blood.2024026381. Online ahead of print. Blood. 2024. PMID: 39786460
Disparities in Utilization of Immune Checkpoint Inhibitor Therapy Among Older Patients With Advanced Non-Small Cell Lung Cancer: A SEER-Medicare Analysis.
Yang D, Karanth SD, Yoon HS, Yang JJ, Lou X, Bian J, Zhang D, Guo Y, Yaghjyan L, Akinyemiju T, Rodriguez E, Mehta HJ, Braithwaite D. Yang D, et al. Among authors: yang jj. JCO Oncol Adv. 2024 Dec 3;1:e2400008. doi: 10.1200/OA.24.00008. eCollection 2024. JCO Oncol Adv. 2024. PMID: 39758136 Free PMC article.
2,322 results